M2I Life Sciences

company

About

A world-class industrial partner for custom synthesis and formulation of niche products in Healthcare.

  • 101 - 250

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€60M
Industries
Biotechnology,Electronics,Health Care,Industrial,Organic,Veterinary
Founded date
Jan 1, 2013
Number Of Employee
101 - 250
Operating Status
Active

M2I Vision :
Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics

(Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability)

Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams

The company operates a R&D center rance and a cGMP manufacturing plant.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€60M
M2I Life Sciences has raised a total of €60M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2020 Debt Financing 1 Detail
Sep 3, 2019 Series Unknown €60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
M2I Life Sciences is funded by 2 investors. Bootstrap Europe and France 2i are the most recent investors.
Investor Name Lead Investor Funding Round
Bootstrap Europe Debt Financing
France 2i Series Unknown